Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke Volume | 4 | 2016 | 531 | 0.510 |
Why?
|
| Metabolic Syndrome | 3 | 2016 | 363 | 0.490 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2016 | 359 | 0.450 |
Why?
|
| Heart Failure | 8 | 2018 | 2307 | 0.410 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 155 | 0.410 |
Why?
|
| Echocardiography | 3 | 2016 | 1138 | 0.380 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 547 | 0.360 |
Why?
|
| Heart Atria | 2 | 2005 | 336 | 0.340 |
Why?
|
| Cultural Diversity | 1 | 2008 | 78 | 0.270 |
Why?
|
| Obesity | 2 | 2016 | 2390 | 0.270 |
Why?
|
| Cardiac Volume | 2 | 2005 | 18 | 0.250 |
Why?
|
| Echocardiography, Doppler | 2 | 2005 | 166 | 0.240 |
Why?
|
| Atrial Function, Left | 1 | 2005 | 36 | 0.220 |
Why?
|
| Pergolide | 1 | 2002 | 5 | 0.200 |
Why?
|
| Exercise Therapy | 1 | 2005 | 175 | 0.190 |
Why?
|
| Antiparkinson Agents | 1 | 2002 | 65 | 0.190 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2002 | 65 | 0.180 |
Why?
|
| Life Style | 1 | 2005 | 444 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 215 | 0.170 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 890 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2003 | 733 | 0.110 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 188 | 0.110 |
Why?
|
| Stroke | 1 | 2003 | 1049 | 0.110 |
Why?
|
| American Heart Association | 1 | 2016 | 321 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 465 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2018 | 423 | 0.110 |
Why?
|
| Hypertension | 2 | 2016 | 1360 | 0.100 |
Why?
|
| Aged | 9 | 2018 | 21261 | 0.090 |
Why?
|
| Sex Factors | 2 | 2008 | 1346 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 60 | 0.090 |
Why?
|
| Middle Aged | 10 | 2018 | 28889 | 0.090 |
Why?
|
| Cardiology | 1 | 2016 | 507 | 0.090 |
Why?
|
| Vascular Stiffness | 1 | 2011 | 83 | 0.080 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 326 | 0.080 |
Why?
|
| Age Factors | 2 | 2008 | 2872 | 0.070 |
Why?
|
| Female | 11 | 2018 | 71186 | 0.070 |
Why?
|
| Myocardium | 2 | 2005 | 874 | 0.070 |
Why?
|
| Male | 11 | 2018 | 65267 | 0.070 |
Why?
|
| Humans | 15 | 2018 | 131680 | 0.070 |
Why?
|
| Aneurysm, Infected | 1 | 2007 | 24 | 0.070 |
Why?
|
| Sinus of Valsalva | 1 | 2007 | 32 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2011 | 1344 | 0.070 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2007 | 61 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 79 | 0.060 |
Why?
|
| Aortic Rupture | 1 | 2007 | 114 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2008 | 5123 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2007 | 251 | 0.060 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2005 | 4 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1309 | 0.060 |
Why?
|
| Texas | 2 | 2018 | 3622 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2005 | 33 | 0.060 |
Why?
|
| Diet, Fat-Restricted | 1 | 2005 | 37 | 0.060 |
Why?
|
| Body Surface Area | 1 | 2005 | 37 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2007 | 224 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2005 | 89 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 97 | 0.050 |
Why?
|
| Risk Factors | 3 | 2016 | 10959 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 5297 | 0.050 |
Why?
|
| Prognosis | 3 | 2016 | 4952 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2005 | 155 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2008 | 506 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2005 | 171 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 475 | 0.050 |
Why?
|
| ROC Curve | 1 | 2005 | 615 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2008 | 983 | 0.050 |
Why?
|
| Random Allocation | 1 | 2003 | 423 | 0.050 |
Why?
|
| Body Composition | 1 | 2005 | 550 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 612 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 865 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 2694 | 0.040 |
Why?
|
| Hospitalization | 1 | 2008 | 1939 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2012 | 17667 | 0.040 |
Why?
|
| Patient Selection | 1 | 2002 | 726 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2002 | 974 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2018 | 77 | 0.030 |
Why?
|
| Telephone | 1 | 2018 | 116 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 2297 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2003 | 1695 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 3834 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2011 | 1521 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 1405 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 1306 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 564 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2012 | 12984 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 565 | 0.030 |
Why?
|
| Adult | 3 | 2011 | 31719 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2016 | 3695 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 644 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2012 | 70 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 2082 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 1234 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1600 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 119 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 197 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1217 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 1153 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 567 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 3347 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2007 | 48 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6279 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 272 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 910 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 1224 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 692 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 741 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2005 | 43 | 0.010 |
Why?
|
| Ligation | 1 | 2005 | 137 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2005 | 90 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 297 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2990 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1686 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2005 | 252 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 323 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2007 | 407 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1626 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 1911 | 0.010 |
Why?
|
| Aorta | 1 | 2005 | 529 | 0.010 |
Why?
|
| United States | 1 | 2016 | 11804 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6925 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1502 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 3454 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 2363 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 3405 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 6177 | 0.010 |
Why?
|
| Mice | 1 | 2005 | 18488 | 0.000 |
Why?
|
| Animals | 1 | 2005 | 34375 | 0.000 |
Why?
|